J.P. Hong博士作为CMO加入MedithinQ公司,推进其数字微外科平台,在中国获得认可,在亚洲获得交易。 Dr. J.P. Hong joins MediThinQ as CMO to advance its digital microsurgery platform, gaining approval in China and deals in Asia.

J.P. Hong教授是全球公认的微观外科专家兼世界再造微生物外科学会会长,他加入了韩国的MedithinQ,担任首席医学官,将临床权威授予该公司的SHIYA 20个数字微观外科平台。 Professor J.P. Hong, a globally recognized microsurgery expert and President of the World Society for Reconstructive Microsurgery, has joined South Korea-based MediThinQ as Chief Medical Officer, lending his clinical authority to the company’s SHIYA 20 digital microsurgery platform. 该平台整合了3D可视化、外镜、可磨损的面罩和实时记录,以提高外科精确度和人类工程学能力。 The platform integrates 3D visualization, exoscopy, a wearable visor, and real-time recording to enhance surgical precision and ergonomics. Hong教授已在现场手术和培训中验证了该系统,支持其在全球推广。 Prof. Hong has validated the system in live surgeries and training, supporting its global adoption. Medi ThinQ通过Sinopharm伙伴关系在中国内地获得监管批准,并在台湾、新加坡和马来西亚建立了独家分销交易。 MediThinQ has secured regulatory approval in Mainland China via a Sinopharm partnership and established exclusive distribution deals in Taiwan, Singapore, and Malaysia. 该公司旨在扩大其数字外科手术生态系统,以促进教育、协作和未来AI驱动的进步。 The company aims to expand its digital surgical ecosystem for education, collaboration, and future AI-driven advancements.